Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Little

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Signal Transduction and Targeted Therapy|May 27, 2023
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapiesXiumei Wu, Mengyun Xu, Mengya Geng, et al.
Pharmacological Research|November 9, 2018
Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potentialXiaojun Feng, Yi Li, Yanan Wang, et al.
Atherosclerosis|August 24, 2024
Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical reviewHirushi Kumarapperuma, Zheng-Jie Chia, Sanchia Marie Malapitan, et al.
Diabetes Research and Clinical Practice|February 1, 2003
High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1Peter J Little, Terri J Allen, Kazuhiko Hashimura, et al.
European Journal of Pharmacology|September 10, 2020
Naringenin and naringin in cardiovascular disease prevention: A preclinical reviewReza Heidary Moghaddam, Zeinab Samimi, Seyed Zachariah Moradi, et al.
Cardiovascular & Hematological Disorders Drug Targets|December 17, 2008
p38 MAP kinase mediated proteoglycan synthesis as a target for the prevention of atherosclerosisNarin Osman, Mandy L Ballinger, Harsha M Dadlani, et al.
Biomed Research International|September 25, 2014
The nerve growth factor signaling and its potential as therapeutic target for glaucomaHaitao Wang, Rikang Wang, Thilini Thrimawithana, et al.
Biochemical and Biophysical Research Communications|September 2, 2020
Artemisinin inhibits glycosaminoglycan chain synthesizing gene expression but not proliferation of human vascular smooth muscle cellsYing Zhou, Hirushi Kumarapperuma, Salifya Sichone, et al.
The FEBS Journal|November 26, 2021
Akt acts as a switch for GPCR transactivation of the TGF-β receptor type 1Raafat Mohamed, Aravindra Shajimoon, Rizwana Afroz, et al.
Brain Research|July 10, 2012
The possible role of the Akt signaling pathway in schizophreniaWenhua Zheng, Haitao Wang, Zhiwen Zeng, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Signal Transduction and Targeted Therapy|May 27, 2023
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapiesXiumei Wu, Mengyun Xu, Mengya Geng, et al.
Pharmacological Research|November 9, 2018
Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potentialXiaojun Feng, Yi Li, Yanan Wang, et al.
Atherosclerosis|August 24, 2024
Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical reviewHirushi Kumarapperuma, Zheng-Jie Chia, Sanchia Marie Malapitan, et al.
Diabetes Research and Clinical Practice|February 1, 2003
High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1Peter J Little, Terri J Allen, Kazuhiko Hashimura, et al.
European Journal of Pharmacology|September 10, 2020
Naringenin and naringin in cardiovascular disease prevention: A preclinical reviewReza Heidary Moghaddam, Zeinab Samimi, Seyed Zachariah Moradi, et al.
Cardiovascular & Hematological Disorders Drug Targets|December 17, 2008
p38 MAP kinase mediated proteoglycan synthesis as a target for the prevention of atherosclerosisNarin Osman, Mandy L Ballinger, Harsha M Dadlani, et al.
Biomed Research International|September 25, 2014
The nerve growth factor signaling and its potential as therapeutic target for glaucomaHaitao Wang, Rikang Wang, Thilini Thrimawithana, et al.
Biochemical and Biophysical Research Communications|September 2, 2020
Artemisinin inhibits glycosaminoglycan chain synthesizing gene expression but not proliferation of human vascular smooth muscle cellsYing Zhou, Hirushi Kumarapperuma, Salifya Sichone, et al.
The FEBS Journal|November 26, 2021
Akt acts as a switch for GPCR transactivation of the TGF-β receptor type 1Raafat Mohamed, Aravindra Shajimoon, Rizwana Afroz, et al.
Brain Research|July 10, 2012
The possible role of the Akt signaling pathway in schizophreniaWenhua Zheng, Haitao Wang, Zhiwen Zeng, et al.
Pageof 19